help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2003-0375
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
145/1/39    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asaba, K.
Right arrow Articles by Hashimoto, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asaba, K.
Right arrow Articles by Hashimoto, K.
Endocrinology Vol. 145, No. 1 39-42
Copyright © 2004 by The Endocrine Society


BRIEF COMMUNICATION

Attenuation by Reactive Oxygen Species of Glucocorticoid Suppression on Proopiomelanocortin Gene Expression in Pituitary Corticotroph Cells

Koichi Asaba, Yasumasa Iwasaki, Masanori Yoshida, Masato Asai, Yutaka Oiso, Toyoaki Murohara and Kozo Hashimoto

Departments of Clinical Pathophysiology (K.A., Y.I.) and Internal Medicine (M.Y., M.A., Y.O., T.M.), Nagoya University Graduate School of Medicine and Hospital, Nagoya 466-8550, Japan; and Second Department of Internal Medicine (K.A., K.H.), Kochi Medical School, Nankoku, Kochi 783-8505, Japan

Address all correspondence and requests for reprints to: Yasumasa Iwasaki, M.D., Ph.D., Department of Pathophysiology, Nagoya University Graduate School of Medicine and Hospital, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. E-mail: iwasakiy{at}med.nagoya-u.ac.jp.

Abstract

Up-regulation of hypothalamo-pituitary-adrenal axis is maintained during acute inflammation and/or infection, in the face of sustained elevation of plasma glucocorticoid hormone. Inflammatory stress is usually associated with high plasma cytokine levels and increased generation of reactive oxygen species (ROS) as well. In this study, we examined the effect of ROS on the negative feedback regulation of glucocorticoid in hypothalamo-pituitary-adrenal axis using AtT20 corticotroph cells in vitro. When the cells were treated with H2O2, glucocorticoid suppression on the proopiomelanocortin gene promoter activity was attenuated in a dose-dependent manner. H2O2 also inhibited the ligand-stimulated nuclear translocation of glucocorticoid receptor. The released glucocorticoid suppression by H2O2 was not observed when the cells were cotreated with antioxidants. Together, these results suggest that increased ROS generation in the oxidative redox state attenuates the glucocorticoid negative feedback system, at least in part, by interfering with the nuclear translocation of glucocorticoid receptor and eliminating the repression on proopiomelanocortin gene expression.

HYPOTHALAMO-PITUITARY-ADRENAL (HPA)-AXIS IS activated by a variety of stresses, and the resultant increase in adrenal glucocorticoid (GC) hormone mediates body defense responses by its antistress effect (1). In addition to the well-known physical or mental stresses, inflammation and/or infection are known to activate HPA axis as well, through the so-called immune-endocrine interaction (2). Indeed, plasma GC level is elevated after infectious/inflammatory stress, which in turn exerts a suppressive effect on the immune function to prevent the overactivation of the system.

If the high GC suppresses the activated immune system, it may also inhibit HPA axis through the well-known negative feedback effect. Nonetheless, the activation of HPA axis is maintained until the inflammation/infection subsides, and thus there should be some mechanism by which GC suppression of neuroendocrine regulation is reduced or abolished in the face of high plasma GC levels.

It is well known that systemic or local generation of reactive oxygen species (ROS) is increased during inflammation and/or infection with increased cytokine production (3, 4, 5), which influences the redox regulation of various intracellular signaling systems. In this study, we have hypothesized that GC suppression of pituitary ACTH expression is somehow reduced so that the set point of negative feedback is shifted to allow continuous stimulation of GC secretion under a high plasma GC level. We especially focused on the effect of ROS on GC receptor (GR) function, because recent studies suggest an impaired function of GR during oxidative stress through redox regulation (6, 7, 8). We found that the impaired nuclear translocation of GR is observed in corticotrophs under high hydroxyradical generation, which may account for the reduced or eliminated effect of glucocorticoid on the expression of the proopiomelanocortin (POMC) gene that encodes ACTH.

Materials and Methods

Plasmids and stable transfection
The expression vector for the green fluorescent protein (GFP)-GR fusion protein was constructed using enhanced GFP expression vector (EGFP-CI; CLONTECH, Palo Alto, CA). When the human GR cDNA (9) was fused with the C terminus of the EGFP gene, two tandem repeats of an amino acid sequence (Gly-Gly-Gly-Ser) were artificially added between the GFP and GR to maintain the flexibility of the fusion protein and the function of GR. For making a stable transformant of GFP-GR, AtT20 murine corticotroph cells were transfected with the expression vector using the lipofection method (TransIT, PanVera, WI), and a clonal cell line, designated as AtT20GG, which expresses the GFP-GR fusion protein, was obtained.

Cell culture
AtT20PL, a clone of the AtT20 cell line in which an approximately 0.7 kb of the rat POMC gene 5'-promoter (-708 to +64; +1 indicates the transcription start site)-luciferase fusion gene is stably incorporated, is described elsewhere (10). Both the AtT20PL and AtT20GG cells were maintained in a T75 culture flask with DMEM (Invitrogen, Carlsbad, CA) supplemented with 10% FBS (Invitrogen) and antibiotics (50 µU/ml penicillin and 50 µg/ml streptomycin; Invitrogen) under 5% CO2/95% atmosphere at 37 C. Culture medium was changed twice a week, and the cells were subcultured once a week.

Experimental protocols
All experiments were performed more than twice to confirm their reproducibility. The culture condition of the cells is mentioned elsewhere (10). For each experiment, forskolin (Sigma, St. Louis, MO) and/or dexamethasone (Sigma) were added to the culture medium of each dish, and the cells were harvested after the defined time interval for luciferase assay. When used, H2O2 (Wako Chemical, Tokyo, Japan) and TEMPOL (Sigma) were added into the culture medium 1 h before the addition of forskolin/dexamethasone. Alternatively, lipopolysaccharide (LPS; from Escherichia coli 055:B5, Sigma) and TEMPOL were added 6 h before the addition of forskolin/dexamethasone.

Measurements and statistics
Luciferase activity was measured as described (10). Results are expressed as mean ± SEM of triplicate or quadruplicate dishes in each group. The statistical significance of differences among the groups was analyzed by ANOVA, followed by a Fisher’s protected least significant difference test at a significance level of 0.05.

Results

GC suppression of POMC gene expression is abolished under ROS excess
We first examined the negative feedback effect of GC on the POMC gene 5'-promoter activity under the environment of ROS overproduction. As shown in Fig. 1Go, under the control condition, dexamethasone (100 nM) potently suppressed the forskolin-induced POMC gene transcription, which is in accordance with the previous reports by Aoki et al. (10). In contrast, the inhibition was completely eliminated in the H2O2-treated group, suggesting the impaired negative feedback regulation under the circumstance with high oxidative stress.



View larger version (22K):
[in this window]
[in a new window]
 
FIG. 1. The effect of H2O2 treatment on glucocorticoid suppression of the POMC gene 5'-promoter activity in AtT20PL cells. Cells were cultured with or without H2O2 (2 mM) for 1 h and then treated with vehicle (closed bar), forskolin (10 µM; open bar), or forskolin plus dexamethasone (100 nM; shaded bar) for 5 h. Each value is shown as a percentage of the basal value. *, P < 0.05 vs. basal value. #, P < 0.05 vs. forskolin alone.

 
The ROS interference of GC negative feedback is dose dependent
We then studied the effect of three different doses of H2O2 pretreatment on the suppressive effect of GC inhibition of the POMC gene. As shown in Fig. 2Go, attenuation of dexamethasone suppression was dose dependent. Dexamethasone still suppressed forskolin-induced POMC gene transcription at 1.0 mM of H2O2, but no inhibition was observed at or above 1.5 mM.



View larger version (27K):
[in this window]
[in a new window]
 
FIG. 2. The dose-response effect of H2O2 treatment on glucocorticoid suppression of the POMC gene 5'-promoter activity in AtT20PL cells. Cells were cultured with or without various concentrations of H2O2 for 1 h and then treated with forskolin (10 µM; open bar) or forskolin plus dexamethasone (100 nM; shaded bar) for 5 h. Each value is shown as a percentage of the value with forskolin alone. *, P < 0.05 vs. forskolin alone.

 
ROS excess prevents nuclear translocation of GR by dexamethasone
Using AtT20GG cells, we also studied the influence of ROS excess on GC-induced nuclear localization of GR. GFP-GR was almost exclusively located in the cytosol in the control condition, and then translocated to the nucleus after the addition of dexamethasone (Fig. 3Go, A and B). Under treatment with H2O2, however, the movement was significantly inhibited and most of GFP-GR was observed in the cytosol (Fig. 3CGo). Thus, our data show that H2O2 treatment interferes with nuclear translocation of GR in corticotroph cells as well as in nonendocrine cells (7) and may partly explain the attenuation of dexamethasone suppression under ROS excess.



View larger version (18K):
[in this window]
[in a new window]
 
FIG. 3. The effect of H2O2 treatment on glucocorticoid-induced nuclear translocation of GR in AtT20GG cells. The cells, which express GFP-GR fusion protein, were treated with vehicle (A), dexamethasone (Dex; 100 nM) (B), or Dex plus H2O2 (2 mM) (C), and subcellular localization of GFP-GR chimeric protein was examined by confocal fluorescence microscopy.

 
The ROS/LPS interference of GC suppression is reversed by treatment with radical scavenger
Finally, to confirm whether the effects of H2O2 observed above were mediated by ROS, we treated the cells with membrane-permeable radical scavenger TEMPOL (11). As shown in Fig. 4Go, H2O2 again abolished the dexamethasone suppression of POMC gene promoter activity. On the other hand, the effect was partly reversed by a simultaneous treatment with TEMPOL (2 mM), and a significant inhibitory effect of dexamethasone was recovered. TEMPOL alone had no effect on basal or forskolin-induced POMC promoter activity (data not shown). In addition, a similar effect was observed when the cells were treated with LPS, a representative bacterial endotoxin. These results suggest that the abolished glucocorticoid suppression by either H2O2 or inflammatory stimulus is indeed caused by oxidative stress.



View larger version (31K):
[in this window]
[in a new window]
 
FIG. 4. The effects of TEMPOL on H2O2 or LPS-induced elimination of dexamethasone suppression on the POMC gene 5'-promoter activity in AtT20PL cells. Cells were incubated with vehicle, H2O2, or H2O2 and TEMPOL (2 mM) for 1 h, and then treated with forskolin (10 µM; open bar) or forskolin plus dexamethasone (100 nM; shaded bar) for 5 h. Alternatively, cells were incubated with LPS (1 µg/ml) or LPS and TEMPOL (2 mM) for 6 h, and then treated with forskolin/dexamethasone for 5 h. Each value is shown as a percentage of the value with forskolin alone. *, P < 0.01 vs. forskolin alone.

 
Discussion

Our results show that ROS diminishes or abolishes GC negative feedback regulation, with impaired GR nuclear translocation probably caused by altered intracellular redox regulation. This is the first evidence suggesting that oxidative stress may also be one of the stresses influencing the regulation of HPA axis.

It is well known that HPA axis is activated by acute infection and/or inflammation. In this situation a variety of cytokines or inflammatory substances produced has been shown to stimulate the expression of CRH and ACTH through immune-neuroendocrine interaction (2, 12), with the resultant increase in adrenal GC production which suppresses overactivation of the immune system. At the same time, increased plasma glucocorticoid hormone is expected to suppress HPA axis as well through negative feedback regulation at the pituitary level, whereas in fact it is maintained to be activated until the end of the event. Thus, some unknown mechanism(s) that release the GC suppression and allow the continuous expression of POMC/ACTH should exist. Our results in this study suggest that ROS, possibly derived from increased leukocyte or activated plasma cytokines, may be involved in this process. Indeed, proinflammatory cytokines such as TNF{alpha}, or endotoxins like LPS, have previously been shown to induce ROS formation in a variety of cells or tissues (13, 14, 15).

It is not completely clear how ROS diminishes or abolishes GC suppression. Okamoto et al. (7) showed that ROS induced by H2O2 treatment inhibits GC-induced nuclear translocation of GR through changes in the intracellular redox state. In this paper, we confirmed a similar phenomenon in corticotroph cells as well, suggesting that impaired translocation of GR may partly explain the release of GC suppression under oxidative stress. Furthermore, recent studies suggest that many transcription factors are redox-sensitive and regulated by intracellular oxidative stress (16). For example, ROS is known to activate nuclear factor {kappa}-B (17), which is known to interfere with GR function (18). ROS may also influence other transcription factors regulating POMC gene expression (19, 20). We speculate that changes in the redox state following inflammation are somehow involved in the diminished or abolished GC repression.

Collectively, our results strongly suggest that the set point of GC negative feedback is shifted to maintain activated HPA axis during inflammation/infection. As shown in Fig. 5Go, in the normal state, CRH stimulation and GC suppression are balanced at the pituitary level, whereas GC suppression is released and CRH stimulation is enhanced during inflammation, with maintenance of up-regulated HPA axis function even in the face of high plasma GC. Our data, although obtained in vitro, may at least partly explain the molecular mechanism of chronic up-regulation of HPA axis under oxidative stress. Further studies will clarify the intracellular events responsible for the host-defense mechanism against a variety of environmental stresses.



View larger version (22K):
[in this window]
[in a new window]
 
FIG. 5. Schematic representation of the effect of oxidative stress on glucocorticoid suppression of POMC gene expression in the corticotroph cells.

 

Acknowledgments

We are indebted to Ms. Machiko Kambayashi and Tatsuyo Miura for excellent technical assistance.

Footnotes

Abbreviations: EGFP, Enhanced GFP; GC, glucocorticoid; GFP, green fluorescent protein; GR, GC receptor; HPA, hypothalamo-pituitary-adrenal; LPS, lipopolysaccharide; POMC, proopiomelanocortin; ROS, reactive oxygen species.

Received March 26, 2003.

Accepted for publication October 3, 2003.

References

  1. Dallman MF, Akana SF, Levin N, Walker CD, Bradbury MJ, Suemaru S, Scribner KS 1994 Corticosteroids and the control of function in the hypothalamo-pituitary-adrenal (HPA) axis. Ann NY Acad Sci 746:22–31[Medline]
  2. Gaillard RC 2001 Interaction between the hypothalamo-pituitary-adrenal axis and the immunological system. Ann Endocrinol (Paris) 62:155–163[Medline]
  3. Akaike T, Suga M, Maeda H 1998 Free radicals in viral pathogenesis: molecular mechanisms involving superoxide and NO. Proc Soc Exp Biol Med 217:64–73[Abstract]
  4. Miesel R, Murphy MP, Kroger H 1996 Enhanced mitochondrial radical production in patients which rheumatoid arthritis correlates with elevated levels of tumor necrosis factor {alpha} in plasma. Free Radic Res 25:161–169[Medline]
  5. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA, Fiers W 1992 Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem 267:5317–5323[Abstract/Free Full Text]
  6. Makino Y, Okamoto K, Yoshikawa N, Aoshima M, Hirota K, Yodoi J, Umesono K, Makino I, Tanaka H 1996 Thioredoxin: a redox-regulating cellular cofactor for glucocorticoid hormone action. Cross talk between endocrine control of stress response and cellular antioxidant defense system. J Clin Invest 98:2469–2477[Medline]
  7. Okamoto K, Tanaka H, Ogawa H, Makino Y, Eguchi H, Hayashi S, Yoshikawa N, Poellinger L, Umesono K, Makino I 1999 Redox-dependent regulation of nuclear import of the glucocorticoid receptor. J Biol Chem 274:10363–10371[Abstract/Free Full Text]
  8. Tanaka H, Makino Y, Okamoto K, Iida T, Yan K, Yoshikawa N 1999 Redox regulation of the glucocorticoid receptor. Antioxid Redox Signal 1:403–423[Medline]
  9. Iwasaki Y, Oiso Y, Saito H, Majzoub JA 1997 Positive and negative regulation of the rat vasopressin gene promoter. Endocrinology 138:5266–5274[Abstract/Free Full Text]
  10. Aoki Y, Iwasaki Y, Katahira M, Oiso Y, Saito H 1997 Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. I: effects of the common secretagogues. Endocrinology 138:1923–1929[Abstract/Free Full Text]
  11. Samuni AM, DeGraff W, Krishna MC, Mitchell JB 2001 Cellular sites of H2O2-induced damage and their protection by nitroxides. Biochim Biophys Acta 1525:70–76[Medline]
  12. Katahira M, Iwasaki Y, Aoki Y, Oiso Y, Saito H 1998 Cytokine regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. Endocrinology 139:2414–2422[Abstract/Free Full Text]
  13. Goossens V, Grooten J, De Vos K, Fiers W 1995 Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc Natl Acad Sci USA 92:8115–8119[Abstract/Free Full Text]
  14. Adamson GH, Billings RE 1992 Tumor necrosis factor induced oxidative stress in isolated mouse hepatocytes. Arch Biochem Biophys 294:223–229[CrossRef][Medline]
  15. Javesghani D, Hussain SN, Scheidel J, Quinn MT, Magder SA 2003 Superoxide production in the vasculature of lipopolysaccharide-treated rats and pigs. Shock 19:486–493[CrossRef][Medline]
  16. Marshall EH, Merchant K, Stamler JS 2000 Nitrosation and oxidation in the regulation of gene expression. FASEB J 14:1889–1900[Abstract/Free Full Text]
  17. Mercurio F, Manning AM 1999 Multiple signals converging on NF-{kappa}B. Curr Opin Cell Biol 11:226–232[CrossRef][Medline]
  18. Nissen RM, Yamamoto KR 2000 The glucocorticoid receptor inhibits NF{kappa}B by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev 14:2314–2329[Abstract/Free Full Text]
  19. Abate C, Patel L, Rauscher 3rd FJ, Curran T 1990 Links Redox regulation of fos and jun DNA-binding activity in vitro. Science 249:1157–1161[Abstract/Free Full Text]
  20. Wu X, Bishopric NH, Discher DJ, Murphy BJ, Webster KA 1996 Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol Cell Biol 16:1035–1046[Abstract]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
145/1/39    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asaba, K.
Right arrow Articles by Hashimoto, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asaba, K.
Right arrow Articles by Hashimoto, K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals